WebJul 27, 2024 · Jul 27, 2024 CytoDyn, which has been fending off lawsuits from directors and shareholders for more than a year, now faces a new challenge from an investor group that is trying to remake the... WebShareholders of record as of September 1, 2024, are entitled to vote at the Annual Meeting. If you have any questions or require any assistance in voting your shares, please contact …
CytoDyn Inc. Announces Adjournment of Annual Meeting …
WebNov 22, 2024 · CytoDyn is a publicly traded late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on Leronlimab, a novel … Quote - Investor Relations :: CytoDyn Inc. (CYDY) In The News - Investor Relations :: CytoDyn Inc. (CYDY) IR Calendar :: CytoDyn Inc. (CYDY) Upcoming Events There are no … WebMar 28, 2024 · Despite having pared its R&D expense down to de minimis amounts, CytoDyn's annualized expenses are running up above $60 million. Fortunately the biggest chunk of that is its non-cash inventory... billy the kid sheriff
EX-99.1 - SEC
WebNov 25, 2024 · VANCOUVER, Wash. - (BUSINESS WIRE) - Dec. November 2024--CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Firm"), a late-stage biotechnology firm growing Leronlimab, a CCR5 antagonist with the potential for a number of therapeutic indications, introduced the preliminary voting outcomes on the 2024 annual assembly, … WebNov 24, 2024 · November 24, 2024 - 4:01 pm. Shareholders Approve All Proposals. VANCOUVER, Wash. CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced the preliminary vote results from the 2024 … WebOct 18, 2024 · Shareholders of record as of September 1, 2024, are entitled to vote at the Annual Meeting. If you have any questions or require any assistance in voting your … billy the kids real name mccarty